Consistent with the LC‐MS/MS data, ELISA analysis verified the abnormal expression of CRP and IGFBP2 in the first‐trimester maternal plasma in women who subsequently developed GDM (Figure 5). This evidence concerns the gene CRP and gestational diabetes.